Antigen News and Research

RSS

Influenza vaccine strategies for broad global access

If an influenza pandemic occurred this year, fewer than one-fifth of the approximately 13 billion vaccine doses needed to fully vaccinate the global population would be available within six months in a best-case scenario.

21 Nov 2007

PSA test in obese men can produce false results

Scientists in the United States suggest a blood test widely used to screen for prostate cancer can be misleading in the case of men who are obese.

20 Nov 2007

Should the UK lower the age for prostate cancer detection in line with the USA?

19 Nov 2007

Some AIDS vaccines may damage the immune system

Researchers in the United States say some of the viruses being used in experimental AIDS vaccines may cause damage to the immune system.

19 Nov 2007

Some viral-vector vaccines may cause more harm than good

Leading efforts to create an HIV vaccine have hinged on the use of viruses as carriers for selected elements of the HIV virus. Recently, however, evidence has emerged that some of these so-called viral vector systems may undermine the immune system and should not be used for vaccine development.

16 Nov 2007

Histochemistry is the golden standard in the diagnosis of carcinosarcomas

The patient in the study was the first case of gastric carcinosarcoma obtained in this part of the world . The patient was admitted by Dr. Tomislav Randjelovic as surgeon and Dr. Branka Filipovic as gastroenterologist.

15 Nov 2007

Is it pancreatitis in acute abdominal pain in acute viral hepatitis?

Hepatitis viruses have a strong tropism for hepatocytes; viral antigen also has been detected in pancreas and gallbladder.

1 Nov 2007

Cancers successfully treated by targeting the viruses that cause them

Researchers at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that cancers can be successfully treated by targeting the viruses that cause them.

31 Oct 2007

Researchers show evidence of 'memory' in cells and molecules

Research to be reported October 29 in the journal Proceedings of the National Academy of Sciences (PNAS) provides evidence that some molecular interactions on cell surfaces may have a "memory" that affects their future interactions.

29 Oct 2007

Nventa Biopharmaceuticals receives new U.S. patent

Nventa Biopharmaceuticals Corporation has announced that the U.S. Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a human papillomavirus (HPV) antigen with or without the use of an adjuvant.

29 Oct 2007

Emerging cancer therapies and novel targets

What are the cancer drugs of tomorrow and how will they be developed? At the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, researchers will present some answers to these and other pressing questions regarding emerging cancer therapeutics.

25 Oct 2007

Influenza vaccine production capacity on the rise

Recent scientific advances and increased vaccine manufacturing capacity have prompted experts to increase their projections of how many pandemic influenza vaccine courses can be made available in the coming years.

24 Oct 2007

In the event of a bird flu pandemic more vaccine will be ready

The World Health Organization (WHO) has revised it's estimate of how much bird flu vaccine could be available were a pandemic scenario to unfold.

24 Oct 2007

Ubiquitin builds up an immune response

Ubiquitin is a small protein, which can be attached to other cellular proteins, a process known as ubiquitination.

22 Oct 2007

Abbott creates one molecule with two antibody functions

Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.

19 Oct 2007

Discovery of new antibody that helps detect type 1 diabetes

Researchers at the Barbara Davis Center for Childhood Diabetes and University of Colorado at Denver and Health Sciences Center's School of Medicine have discovered a fourth antibody in human blood which will help more accurately predict who is predisposed to type 1 diabetes.

17 Oct 2007

A tumor marker Ca 19-9 in diabetics can lead to misdiagnosis of pancreatic cancer

Diabetes is increasing all over the world along with the increase of obesity and associated diseases and is a well-known risk factor for pancreatic cancer. The incidence of pancreatic cancer is also increasing and has one of the lowest survival rates of all cancers.

16 Oct 2007

Discovery of way to match pathogens to their antibodies

The search for a vaccination against HIV has been in progress since 1984, with very little success.

15 Oct 2007

AMDL submits data to FDA for clearance to market its diagnostic test to monitor colorectal cancer patients

AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.

15 Oct 2007